Items where authors include "Barrett, J.R."

Article

Nielsen, C.M. orcid.org/0000-0002-9033-1318, Barrett, J.R. orcid.org/0000-0003-0746-1945, Davis, C. orcid.org/0000-0002-5022-2838 et al. (22 more authors) (2023) Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine. JCI Insight, 8 (2). e163859. ISSN 2379-3708

Minassian, A.M., Silk, S.E., Barrett, J.R. et al. (47 more authors) (2021) Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination. Med, 2 (6). 701-719.e19. ISSN 2666-6340

Nielsen, C.M., Ogbe, A., Pedroza-Pacheco, I. et al. (17 more authors) (2021) Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors. Cell Reports Medicine, 2 (3). 100207. ISSN 2666-3791

Ramasamy, M.N., Minassian, A.M., Ewer, K.J. et al. (418 more authors) (2020) Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. The Lancet, 396 (10267). pp. 1979-1993. ISSN 0140-6736

Jin, J., Tarrant, R.D., Bolam, E.J. et al. (29 more authors) (2018) Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells. npj Vaccines, 3 (1).